Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
About Us
Scientific Advisors
Prof Charles Warren Olanow, M.D., F.R.C.P(C)
-
Departments of Neurology and Neuroscience Mount Sinai School of Medicine New York, New York
Prof. Olanow obtained his M.D degree from the University of Toronto and completed a Residency in Neurology and a Fellowship in Neuroanatomy at Columbia University in New York.
After holding teaching appointments at the McGill, Duke and Tampa Universities he became Professor and Chair of the Department of Neurology at Mount Sinai School of Medicine in New York City.
Dr Olanow’s research and clinical interest have centered on the pathophysiology and treatment of movement disorders, Parkinson’s disease in particular. He is recognized worldwide as an opinion leader in the field and called upon as a consultant by all major players in the Academic, Health Care and Industrial fields.